These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. What causes neuropathic pain? Boulton A J Diabetes Complications; 1992; 6(1):58-63. PubMed ID: 1562760 [TBL] [Abstract][Full Text] [Related]
5. Short term fluctuations in blood glucose concentrations do not alter pain perception in diabetic-patients with and without painful peripheral neuropathy. Chan AW; MacFarlane IA; Bowsher D Diabetes Res; 1990 May; 14(1):15-9. PubMed ID: 2134661 [TBL] [Abstract][Full Text] [Related]
6. On "The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy" by Bach et al. in Pain, 40 (1990) 29-34. Coe AJ; Dean J; McClone F; Leijon G; Bowsher D Pain; 1991 Aug; 46(2):232. PubMed ID: 1749647 [No Abstract] [Full Text] [Related]
8. Systemic lidocaine or mexiletine for neuropathic pain. Ebell MH Am Fam Physician; 2006 Jul; 74(1):79. PubMed ID: 16848381 [No Abstract] [Full Text] [Related]
9. Mexiletine for treatment of chronic painful diabetic neuropathy. Dejgard A; Petersen P; Kastrup J Lancet; 1988 Jan 2-9; 1(8575-6):9-11. PubMed ID: 2891940 [TBL] [Abstract][Full Text] [Related]
10. Understanding the impact of painful diabetic neuropathy. Quattrini C; Tesfaye S Diabetes Metab Res Rev; 2003; 19 Suppl 1():S2-8. PubMed ID: 12577252 [TBL] [Abstract][Full Text] [Related]
11. [Diabetic neuropathy--sensory abnormalities and treatment for painful neuropathy]. Suzuki K; Toyota T Nihon Rinsho; 1991 Feb; 49 Suppl():180-5. PubMed ID: 1851897 [No Abstract] [Full Text] [Related]
12. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Jarvis B; Coukell AJ Drugs; 1998 Oct; 56(4):691-707. PubMed ID: 9806111 [TBL] [Abstract][Full Text] [Related]
13. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Tanelian DL; Brose WG Anesthesiology; 1991 May; 74(5):949-51. PubMed ID: 1850581 [No Abstract] [Full Text] [Related]
14. The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy. Ackerman WE; Colclough GW; Juneja MM; Bellinger K J Ky Med Assoc; 1991 Oct; 89(10):500-1. PubMed ID: 1744511 [TBL] [Abstract][Full Text] [Related]
15. Impaired insulin signaling as a potential trigger of pain in diabetes and prediabetes. Dobretsov M; Ghaleb AH; Romanovsky D; Pablo CS; Stimers JR Int Anesthesiol Clin; 2007; 45(2):95-105. PubMed ID: 17426511 [No Abstract] [Full Text] [Related]
16. Mexiletine in the treatment of diabetic neuropathy. Stracke H; Meyer UE; Schumacher HE; Federlin K Diabetes Care; 1992 Nov; 15(11):1550-5. PubMed ID: 1468285 [TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Kiguchi S; Imamura T; Ichikawa K; Kojima M Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685 [TBL] [Abstract][Full Text] [Related]
19. Acute painful neuropathy restricted to the abdomen following rapid glycaemic control in type 2 diabetes. Takayama S; Takahashi Y; Osawa M; Iwamoto Y J Int Med Res; 2004; 32(5):558-62. PubMed ID: 15458290 [TBL] [Abstract][Full Text] [Related]
20. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. Sakurai M; Kanazawa I J Neurol Sci; 1999 Jan; 162(2):162-8. PubMed ID: 10202981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]